LeMaitre Vascular, Inc. (FRA:LHU)

Market Cap	2.20B +34.3%
Revenue (ttm)	212.59M +13.5%
Net Income	49.17M +31.1%
EPS	2.15 +30.6%
Shares Out	n/a
PE Ratio	44.78
Forward PE	38.49
Dividend	0.74 (0.78%)
Ex-Dividend Date	Mar 12, 2026

Volume	n/a
Average Volume	2
Open	96.00
Previous Close	95.00
Day's Range	96.00 - 96.00
52-Week Range	67.50 - 99.00
Beta	n/a
RSI	52.45
Earnings Date	May 5, 2026

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheter...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1983
• Employees: 655
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LHU

Financial Performance

In 2025, LeMaitre Vascular's revenue was $249.60 million, an increase of 13.53% compared to the previous year's $219.86 million. Earnings were $57.73 million, an increase of 31.10%.

Financial numbers in USD